The role of ifosfamide in the treatment of lymphomas. - Wikidata - wikimedia - TriplyDB

The role of ifosfamide in the treatment of lymphomas.

The role of ifosfamide in the treatment of lymphomas.

http://www.wikidata.org/entity/Q33735172

about

Salvage therapy with gemcitabine, ifosfamide, dexamethasone, and oxaliplatin (GIDOX) for B-cell non-Hodgkin's lymphoma: a consortium for improving survival of lymphoma (CISL) trial.Urological implications of cyclophosphamide and ifosfamide.Nonconvulsive status epilepticus due to ifosfamide.

P2860

Q33386243-6412B3C0-F710-4D7C-BCFF-1FF52EB72CAD Q37264407-42561E20-86C1-4C78-97CA-E5F56E509C54 Q46921571-7894AD0E-7123-44B0-AB66-915BB2653FF8

P2860

The role of ifosfamide in the treatment of lymphomas.

http://www.wikidata.org/entity/Q33735172

description

1999 nî lūn-bûn

@nan

1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

The role of ifosfamide in the treatment of lymphomas.

@ast

The role of ifosfamide in the treatment of lymphomas.

@en

type

label

The role of ifosfamide in the treatment of lymphomas.

@ast

The role of ifosfamide in the treatment of lymphomas.

@en

prefLabel

The role of ifosfamide in the treatment of lymphomas.

@ast

The role of ifosfamide in the treatment of lymphomas.

@en

P1433

Q33735172-D551E6E0-D92A-41F6-9DE7-6E709172BE25

P1476

Q33735172-61ABEC31-9553-4FDC-9C81-7336C2EB1F66

P2093

Q33735172-69BAC75C-465D-4B17-AA9C-222A7F879D30

P2860

Q33735172-0EA72B82-DA2B-4326-9F51-EEA86D6B256A

Q33735172-20063605-C68D-400B-A3B9-D82EF856B264

Q33735172-2CF22C5B-BC5C-4516-894E-50D95817A224

Q33735172-42592714-8238-407C-8F09-5A7AF19C833A

Q33735172-61235715-4F74-41A6-A010-EA68D1A29603

Q33735172-725D7D44-F5FC-4F25-85EA-85F3E4A2A517

Q33735172-7D4C2670-CF81-4EAC-BF6D-15BC44B0B7CB

Q33735172-A76F11D9-167B-4664-8541-95F415DBA09A

Q33735172-AAA8B02D-8B04-4876-951C-D33B5315FCB4

Q33735172-C126789E-8918-4181-ADC6-998B26972AB2

P304

Q33735172-8C141FC8-853E-439D-B6C2-DA900BAAD8AB

P31

Q33735172-C9FA3787-647F-409C-A57A-F64EBA913E30

P356

Q33735172-CC4641DB-EAB6-477C-A289-CA983ED6AEB1

P433

Q33735172-F02D678B-3955-470B-8047-0B59C415E628

P478

Q33735172-C2ABF98A-18D9-4F2D-8B37-9990D13BFAD5

P577

Q33735172-5E9B7AC5-E7E4-481C-BC3F-9AC7731C2940

P698

Q33735172-6C4C8C4E-5035-4FAD-BB7F-9667CAD57798

P356

10428199909058470

P1433

Leukemia & Lymphoma

P1476

The role of ifosfamide in the treatment of lymphomas.

@en

P2093

Hagemeister FB

http://www.w3.org/2001/XMLSchema#string

P2860

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

EPIC: an effective low toxicity regimen for relapsing lymphoma.

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma.

The role of radiation therapy in the management of the non-Hodgkin's lymphomas.

Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma.

High-dose chemotherapy with carboplatin, etoposide and ifosfamide followed by autologous stem cell rescue in patients with relapsed or refractory malignant lymphomas: a phase I/II study.

Non-Hodgkin's lymphomas in elderly patients.

Treatment of non-Hodgkin's lymphoma.

Brief chemotherapy and involved field radiation therapy for limited-stage, histologically aggressive lymphoma.

P304

433-441

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10428199909058470

http://www.w3.org/2001/XMLSchema#string

P433

5-6

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

1999-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10492066

http://www.w3.org/2001/XMLSchema#string